Tff Pharmaceuticals Inc's ROA from the third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Tff Pharmaceuticals Inc's ROA in the third quarter of 2024?
Tff Pharmaceuticals Inc recorded a cumulative net loss of $-19 million during 12 months ending in the third quarter of 2024, resulting in a negative return on assets (ROA) of -112.25%.

However, within the Healthcare sector 942 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2024 from 4855 to 4862.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter
Y / Y Total Assets Change	-40.51 %	-16.93 %	-49.56 %	28.4 %	-26.41 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-19	-19	-20	-21	40
Return On Assets (TTM)	-112.25 %	-107.65 %	-107.24 %	-101.94 %	211.15 %
TFFP's Total Ranking	# 4862	# 4855	# 4897	# 5611	# 27
Total Assets (TTM) in million	9	11	9	37	15
Seq. Total Assets Change	-21.45 %	22.7 %	-74.96 %	146.48 %	9.7 %
Seq. Net Income Change	-	-	-	-	-

TFFP's 5 Years Annual ROA >> Back to TFFP Management Effectiveness >> Compare TFFP ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 460
Sector	# 943
Overall	# 4765

Return On Assets Statistics
High	Average	Low
224.43 %	-50.14 %	-196.06 %
(Sep 30 2023)		(Sep 30 2024)

Financial Statements
Tff Pharmaceuticals Inc's Assets	$ 9 million	TFFP's Balance sheet
Tff Pharmaceuticals Inc's Income	$ -4 million	Quarterly TFFP's Income Statement
TFFP's Income by Division		See TFFP's Income by Division

Annual Return On Assets	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019
Y / Y Total Assets Change	52.21 %	-40.77 %	-14.65 %	44.48 %	-
Total Assets in million	37	24	41	48	33
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-21	-32	-31	-19	-12
Annual Return On Assets	-57.9 %	-131.81 %	-76.27 %	-38.94 %	-35.97 %

TFFP's 5 Years Annual ROA >> Back to TFFP Management Effectiveness >> Compare TFFP ROA to its Competitors

More Return On Assets Ratios
TFFP's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TFFP's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TFFP's Competitors
Subscribers only: Roa for Tff Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Assets for TFFP's Customers

You may also want to know
TFFP's Roi	TFFP's Inventory Turnover Ratio	TFFP's Growth Rates	TFFP's Dividend Comparisons
	TFFP's Profitability Ratios	TFFP's Asset Turnover Ratio	TFFP's Dividend Growth
TFFP's Roe	TFFP's Valuation Ratios	TFFP's Financial Strength Ratios	TFFP's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2024, within Healthcare Sector

ROA

Date modified: 2026-09-18T13:11:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.